|
|
|
|
PRESCRIPTION ROZEREM
Rozerem is a prescription insomnia medication that targets
the normal sleep-wake cycle by selectively binding to MT1
and MT2 receptors in the body's master clock. It acts by
stimulating receptors for melatonin in the person’s brain.
Melatonin and its receptors control the circadian rhythm of
the body, which in turn, controls the sleep/wake cycle.
Unlike many drugs used for treating insomnia, Rozerem is not
addictive, and it is not a controlled substance. Rozerem
also does not cause withdrawal symptoms or rebound insomnia
when it is stopped.
DOSAGE OF ROZEREM
Only one tablet of 8 mg Rozerem is recommended per day that
to before 30 minutes of bedtime. Rozerem should not be taken
after heavy meal because fat increases its absorption from
the intestine.
USAGE OF ROZEREM
The new drug Rozerem works differently compared to other
sleeping pills on the market. Rozerem has fewer side effects
and is indicated for longterm use. United States DEA has not
classified Rozerem as a controlled substance. Rozerem has
received approval from the US Food and Drugs Administration
for wide marketing of the product. Rozerem has not been
associated with effects on balance and memory, unlike other
sleeping medicines—Rozerem does not work in areas of the
brain that control those functions. Other prescription sleep
medicines may affect not only sites in the brain that are
involved in sleep, but also those that are not—including
sites that are associated with balance and memory. Rozerem
is a registered trademark of Takeda Pharmaceutical Company
Ltd. |
|
|
|
|
